An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

about

Role of abnormal repolarization in the mechanism of cardiac arrhythmia.Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide.

P2860

Q39434566-8663B04C-0132-4158-94D4-2C77A00997EC Q43070404-9981F1EB-4E8C-4A5A-86CA-2BC6BA236B0D

P2860

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

Item

http://www.wikidata.org/entity/Q53623654

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@en

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@nl

type

Item

label

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@en

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@nl

prefLabel

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@en

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@nl

P1476

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

@en

P2093

Kevin N Oguayo

http://www.w3.org/2001/XMLSchema#string

Ola O Oyetayo

http://www.w3.org/2001/XMLSchema#string

Steven M Costa

http://www.w3.org/2001/XMLSchema#string

Timothy A Mixon

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

A method for estimating the probability of adverse drug reactions

Flecainide induced ventricular tachycardia (torsades de pointes).

Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia.

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

Drug therapy. Flecainide.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.

P304

e30-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1403

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24510469

http://www.w3.org/2001/XMLSchema#string

P921

cardiac arrest

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

about

P2860

P2860

An unusual case of flecainide-induced QT prolongation leading to cardiac arrest.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921